Scheiblhofer Sandra, Weiss Richard, Thalhamer Josef
Christian-Doppler-Labor für Allergiediagnostik und Therapie, Fachbereich Molekulare Biologie, Universität Salzburg, Hellbrunnerstrasse 34, 5020 Salzburg, Austria.
Wien Med Wochenschr. 2007;157(5-6):111-5. doi: 10.1007/s10354-007-0392-z.
Gene vaccines have proven to be a powerful tool to induce anti-allergic immune responses. Their underlying functional principle is based on the recruitment of allergen-specific Th1 cells and the establishment of a Th1 cytokine milieu, which protects against the development of a Th2-biased response and balances an already ongoing Th2-type response. Genetic immunization also offers novel approaches to the major problems associated with protein immunization, such as crosslinking of preexisting IgE on mast cells/basophils or induction of de novo synthesis of IgE by the protein immunization itself. In addition to the description of the principles of gene vaccination, this review gives a short overview of recently developed anti-allergic gene vaccines with an optimized efficacy and safety profile.
基因疫苗已被证明是诱导抗过敏免疫反应的有力工具。其潜在的功能原理基于招募过敏原特异性Th1细胞并建立Th1细胞因子环境,这可防止偏向Th2的反应发展,并平衡已在进行的Th2型反应。基因免疫还为与蛋白质免疫相关的主要问题提供了新方法,例如肥大细胞/嗜碱性粒细胞上预先存在的IgE交联或蛋白质免疫本身诱导IgE的从头合成。除了描述基因疫苗接种的原理外,本综述还简要概述了最近开发的具有优化疗效和安全性的抗过敏基因疫苗。